Correlation Between Tata Consultancy and Sun Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tata Consultancy and Sun Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tata Consultancy and Sun Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tata Consultancy Services and Sun Pharmaceutical Industries, you can compare the effects of market volatilities on Tata Consultancy and Sun Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tata Consultancy with a short position of Sun Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tata Consultancy and Sun Pharmaceutical.

Diversification Opportunities for Tata Consultancy and Sun Pharmaceutical

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Tata and Sun is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Tata Consultancy Services and Sun Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sun Pharmaceutical and Tata Consultancy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tata Consultancy Services are associated (or correlated) with Sun Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sun Pharmaceutical has no effect on the direction of Tata Consultancy i.e., Tata Consultancy and Sun Pharmaceutical go up and down completely randomly.

Pair Corralation between Tata Consultancy and Sun Pharmaceutical

Assuming the 90 days trading horizon Tata Consultancy Services is expected to generate 1.13 times more return on investment than Sun Pharmaceutical. However, Tata Consultancy is 1.13 times more volatile than Sun Pharmaceutical Industries. It trades about -0.02 of its potential returns per unit of risk. Sun Pharmaceutical Industries is currently generating about -0.03 per unit of risk. If you would invest  450,671  in Tata Consultancy Services on September 12, 2024 and sell it today you would lose (7,926) from holding Tata Consultancy Services or give up 1.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.41%
ValuesDaily Returns

Tata Consultancy Services  vs.  Sun Pharmaceutical Industries

 Performance 
       Timeline  
Tata Consultancy Services 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tata Consultancy Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Tata Consultancy is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Sun Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sun Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Sun Pharmaceutical is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Tata Consultancy and Sun Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tata Consultancy and Sun Pharmaceutical

The main advantage of trading using opposite Tata Consultancy and Sun Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tata Consultancy position performs unexpectedly, Sun Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sun Pharmaceutical will offset losses from the drop in Sun Pharmaceutical's long position.
The idea behind Tata Consultancy Services and Sun Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
CEOs Directory
Screen CEOs from public companies around the world